10 Low Risk High Reward Stocks Set to Triple by 2030
The market is getting tough these days with increasing interest rates, tense world politics, and inconsistent economic conditions, and investors are constantly looking for opportunities.
Day One Biopharmaceuticals Inc. (DAWN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | BIT Capital GmbH Jan Beckers | 116,565 | $924,360 | -33% | 0.08% |
| 2. | Antipodes Partners Jacob Mitchell | 2,043 | $16,202 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.97 | 111,387 | Large Shareholder | 12,929,322 | 2023-10-20 | Filing | |
| $10.06 | 384,400 | Large Shareholder | 12,817,935 | 2023-10-19 | Filing | |
| $10.21 | 979,667 | Large Shareholder | 12,433,535 | 2023-10-18 | Filing | |
| $13.00 | 769,230 | Large Shareholder | 11,453,868 | 2023-06-09 | Filing | |
| $15.00 | 766,667 | Large Shareholder | 766,667 | 2022-06-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.96 | 4,370 | 252,638 | 2025-02-18 | Filing | ||
| $11.96 | 4,646 | 39,602 | 2025-02-18 | Filing | ||
| $11.96 | 12,048 | 128,015 | 2025-02-18 | Filing | ||
| $13.31 | 30,000 | 1,034,015 | 2024-12-10 | Filing | ||
| $13.21 | 10,554 | 108,377 | 2024-11-18 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,757,929 | $53,590,376 | 0% | |
| 2. | 5,943,243 | $47,129,916 | 0% | |
| 3. | 3,635,580 | $28,830,149 | 0.03% | |
| 4. | 1,569,918 | $12,449,450 | 0% | |
| 5. | 528,148 | $4,188,214 | 0% |
News See All
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q1 2025 Earnings Call Transcript
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q1 2025 Earnings Call Transcript May 6, 2025Day One Biopharmaceuticals, Inc. beats earnings expectations.
10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
Day One Biopharmaceuticals, Inc. (DAWN): A Bull Case Theory
We came across a bullish thesis on Day One Biopharmaceuticals, Inc. (DAWN) on Twitter by Pharmdca. In this article, we will summarize the bulls’ thesis on DAWN. Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q4 2024 Earnings Call Transcript
Operator: Hello, ladies and gentlemen, and welcome to the Day One Biopharmaceuticals Fourth Quarter and Full Year 2024 Financial and Operating Results Conference Call.
Billionaire Andreas Halvorsen's Top 15 Long-Term Stock Picks
Andreas Halvorsen is a prominent Norwegian hedge fund manager and the co-founder of Viking Global, one of the most successful equity-focused hedge funds in the world.
10 Best Up and Coming Stocks To Buy According to Analysts
Donald Trump's victory in the recent presidential election is expected to encourage companies that have been hesitant to pursue IPOs in 2025, capitalizing on the positive market reaction and anticipated...
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q3 2024 Earnings Call Transcript
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q3 2024 Earnings Call Transcript October 30, 2024Day One Biopharmaceuticals, Inc. beats earnings expectations.
10 Biggest Stocks with Negative Beta to Consider
Beta is a measurement of market risk or volatility that indicates how much the price of a stock tends to fluctuate up and down compared to other stocks.
13 Best Biotech Stocks To Buy Under $20
In this article, we're going to take a look at 13 best biotech stocks to buy under $20.
Billionaire Hedge Funds
